Replies to post #228811 on Cytodyn Inc (CYDY)

[tmac20]

If you can't see how this company and it's BOD woefully didn't oversee the shoddy management team and all their shenanigans, you can just keep hoping for something. The fact remains, they don't have the management team or team of employees (read employees not consultants) to get a drug through the process. I don't care how many papers are published or articles you can dig up on obscure websites, everything goes through the FDA and they don't know how to navigate it. Why blindly look the other way at all their missteps and failed objectives? They are still on hold and have been for 2 years. As a shareholder, you should demand more than a string of interim CEOs and overpaid management. 1.7M in compensation for AM - you don't think that is self-enrichment for a non revenue drug that has been on hold for 2 years? You can't be that gung-ho for this drug that you think that is normal.

[justdafactss]

Dr NP.....didn’t write papers .. Um, moosiu, do you say dumb shit/lie for attention or for people to chit chat with you online?

Author contributions
BKP, HS, KD, KK, JL, SK, NP, and JBS conceived the study, HS and EA coordinated patient care, JAO, PAM, MP, LCN, RG, JAO, PAM, and OA led control patient recruitment, BKP, HS, AP, EBF, HR, WR, AL, LK, MH, EH, JAO, and PM acquired data, BKP, MJC, APSP, CS, BF, HLW, GMW, BSP, SK, JL, AL, LK, MH, EH, LCN, and NP analyzed data, and BKP, MJC, KD, JL, HLW, GMW, BSO, SK, NP, LCN, and JBS wrote the manuscript.
https://www.sciencedirect.com/science/article/pii/S1201971220323055

But wait, heres more---

https://scholar.google.com/scholar?hl=en&as_sdt=0%2C37&q=nader+pourhassan&btnG=

[Monroe1]

Just about what I was going to write. Thanks

$CYDY$
Shorts and bashers are in for a real awakening this year.